Iridex (IRIX) Free Cash Flow (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -397.31% |
| Jan 3, 2026 | 141.25% |
| Sep 27, 2025 | -185.61% |
| Jun 28, 2025 | 64.66% |
| Mar 29, 2025 | 6.98% |
| Dec 28, 2024 | 59.43% |
| Sep 28, 2024 | -131.83% |
| Jun 29, 2024 | 19.69% |
| Mar 30, 2024 | -74.34% |
| Dec 30, 2023 | 49.20% |
| Sep 30, 2023 | -61.11% |
| Jul 1, 2023 | 59.91% |
| Apr 1, 2023 | -72.50% |
| Dec 31, 2022 | 22.65% |
| Oct 1, 2022 | 19.59% |
| Jul 2, 2022 | 17.96% |
| Apr 2, 2022 | -129.49% |
| Sep 26, 2020 | 120.13% |
| Jun 27, 2020 | -31.30% |
| Mar 28, 2020 | -692.19% |
| Dec 28, 2019 | 92.55% |
| Sep 28, 2019 | -83.03% |
| Jun 29, 2019 | 63.56% |
| Mar 30, 2019 | -84.00% |
| Dec 29, 2018 | 28.52% |
| Sep 29, 2018 | -21.10% |
| Jun 30, 2018 | 19.16% |
| Mar 31, 2018 | -211.31% |
| Dec 30, 2017 | 51.58% |
| Sep 30, 2017 | -355.91% |
| Jul 1, 2017 | 139.63% |
| Apr 1, 2017 | -222.33% |
| Dec 31, 2016 | 70.41% |
| Oct 1, 2016 | -300.98% |
| Jul 2, 2016 | 134.32% |
| Apr 2, 2016 | 111.95% |
| Sep 27, 2014 | 104.61% |
| Jun 28, 2014 | 0.93% |
| Mar 29, 2014 | 173.06% |
| Dec 28, 2013 | -239.20% |
| Sep 28, 2013 | -48.13% |
| Jun 29, 2013 | 340.09% |
| Mar 30, 2013 | -231.27% |
| Dec 29, 2012 | 154.33% |
| Sep 29, 2012 | 120.52% |
| Jun 30, 2012 | 54.59% |
| Mar 31, 2012 | -193.16% |
| Dec 31, 2011 | 30.51% |
| Oct 1, 2011 | 393.83% |
| Jul 2, 2011 | 129.75% |